Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: DR. BOND who wrote (5581)	2/21/1998 12:19:00 PM
From: RT	Respond to of 23519

DR. BOND, If your ( possible) explanation is correct then Vivus must have many frustrated customers at this time. Hopefully, monday you may have some additional answers. Thanks, RT

To: DR. BOND who wrote (5581)	2/25/1998 9:42:00 PM
From: Ya Who	Respond to of 23519

Interpretation of Script and Refill Numbers Dr. Bond, have you been able to obtain the information required to correctly interpret these numbers. Specifically, if a new MUSE customer starts with an Rx of 6 doses, assuming it is effective, when he runs out does he refill the original Rx (ie; becoming a refill #) or is he given a new Rx (ie; becoming a new Rx #)? Should we interpret that early satisfied users (current repeat users) appear in the most recent months as new Rx or refills? Many thanks - keep up the good work.